1887

Abstract

We have reported previously the enhancement of the infectivity of human immunodeficiency virus type 1 (HIV-1) by liposomes composed of the cationic lipid -[2, 3-(dioleyloxy) propyl]--trimethylammonium chloride (DOTMA). To determine the mechanism by which this process occurs, we have investigated the role of CD4, serum concentration and liposome-cell interactions in the DOTMA-mediated stimulation of HIV-1 infection of A3.01 cells. Serum alone significantly inhibited the binding and infectivity of HIV-1, but DOTMA-mediated enhancement of infectivity was more pronounced in the presence of serum than in its absence. HIV-1 binding to cells was increased in the presence of DOTMA liposomes, DEAE-dextran and polybrene, all of which also enhanced infectivity to a similar extent at comparable concentrations. Fluorescence dequenching measurements indicated that DOTMA liposomes fused with HIV-1, but not with cell membranes, in the presence of serum. The enhancing effect of DOTMA liposomes on HIV-1 infectivity was CD4-dependent, and appeared to involve virus-liposome fusion and liposome binding to the cell surface. DOTMA liposomes did not mediate infection of the CD4 K562 and Raji cell lines.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-72-11-2685
1991-11-01
2024-04-22
Loading full text...

Full text loading...

/deliver/fulltext/jgv/72/11/JV0720112685.html?itemId=/content/journal/jgv/10.1099/0022-1317-72-11-2685&mimeType=html&fmt=ahah

References

  1. Aloia R. C., Jensen F. C., Curtain C. C., Mobley O. W., Gordon L. M. 1988; Lipid composition and fluidity of the human immunodeficiency virus. Proceedings of the National Academy of Sciences, U.S.A. 85:900–904
    [Google Scholar]
  2. Bangham A. D., Standish M. M., Watkins J. C. 1965; Diffusion of univalent ions across lamellae of swollen phospholipids. Journal of Molecular Biology 13:238–252
    [Google Scholar]
  3. Bosch M. L., Earl P. L., Fargnoli K., Picciafuoco S., Giombini F., Wong-Staal F., Franchini G. 1989; Identification of the fusion peptide of primate immunodeficiency viruses. Science 244:694–697
    [Google Scholar]
  4. Busso M. E., Resnick L. 1990; Anti-human immunodeficiency virus effects of dextran sulfate are strain dependent and synergistic or antagonistic when dextran sulfate is given in combination with dideoxynucleosides. Antimicrobial Agents and Chemotherapy 34:1991–1995
    [Google Scholar]
  5. Byrn R. A., Sekigava I., Chamow S. M., Johnson J. S., Gregory T. J., Capon D. J., Groopman J. E. 1989; Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4. Journal of Virology 63:4370–4375
    [Google Scholar]
  6. Cao Y., Friedman-Kien A. E., Huang Y., Li X. L., Mirabile M., Moudgil T., Zucker-Franklin D., Ho D. D. 1990; CD4-independent, productive human immunodeficiency virus type 1 infection of hepatoma cell lines in vitro. Journal of Virology 64:2553–2559
    [Google Scholar]
  7. Centers for Disease Control 1988; 1988 Agent summary statement for human immunodeficiency virus and report on laboratory-acquired infection with human immunodeficiency virus. Morbidity and Mortality Weekly Report 37:Supplement S-4 1–17
    [Google Scholar]
  8. Cheng-Mayer C., Rutka J. T., Rosenblum M. L., McHugh T., Stites D. P., Levy J. A. 1987; Human immunodeficiency virus can productively infect cultured human glial cells. Proceedings of the National Academy of Sciences, U.S.A. 84:3526–3530
    [Google Scholar]
  9. Chesebro B., Wehrly K. 1988; Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity. Journal of Virology 62:3779–3788
    [Google Scholar]
  10. Chesebro B., Buller R., Portis J., Wehrly K. 1990; Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells. Journal of Virology 64:215–221
    [Google Scholar]
  11. Clapham P. R., Weber J. N., Whitby D., McIntosh K., Dalgleish A. G., Maddon P. J., Deen K. C., Sweet R. W., Weiss R. A. 1989; Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature, London 337:368–370
    [Google Scholar]
  12. Dalgleish A. G., Beverley P. C. L., Clapham P. R., Crawford D. H., Greaves M. F., Weiss R. A. 1984; The CD4(T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature, London 312:763–767
    [Google Scholar]
  13. Debs R. J., Freedman L. P., Edmunds S., Gaensler K. L., Düzgüneș N., Yamamoto K. R. 1990; Regulation of gene expression in vivo by liposome-mediated delivery of a purified transcription factor. Journal of Biological Chemistry 265:10189–10192
    [Google Scholar]
  14. Dewhurst S., Sakai K., Bresser J., Stevenson M., Evinger-Hodges M. J., Volsky D. J. 1987; Persistent productive infection of human glial cells by human immunodeficiency virus (HIV) and by infectious molecular clones of HIV. Journal of Virology 61:3774–3782
    [Google Scholar]
  15. Düzgüneș N., Bentz J. 1988; Fluorescence assays for membrane fusion. In Spectroscopic Membrane Probes pp 117–159 Edited by Loew L. Boca Raton: CRC Press;
    [Google Scholar]
  16. Düzgüneș N., Wilschut J., Hong K., Fraley R., Perry C., Friend D. S., James T. L., Papahadjopoulos D. 1983; Physicochemical characterization of large unilamellar vesicles prepared by reverse-phase evaporation. Biochimica et biophysica acta 732:289–299
    [Google Scholar]
  17. Düzgüneș N., Goldstein J. A., Friend D. S., Felgner P. L. 1989; Fusion of liposomes containing a novel cationic lipid, V-[2, 3-(dioleyloxy)propyl]-.N, N, N-trimethylammonium: induction by multivalent anions and asymmetric fusion with acidic phospholipid vesicles. Biochemistry 28:9179–9184
    [Google Scholar]
  18. Ezekowitz A. B., Kuhlman M., Groopman J. E., Byrn R. A. 1989; A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. Journal of Experimental Medicine 169:185–196
    [Google Scholar]
  19. Felgner P. L., Ringold G. M. 1989; Cationic liposome-mediated transfection. Nature, London 337:387–388
    [Google Scholar]
  20. Felgner P. L., Gadek T. R., Holm M., Roman R., Chan H. W., Wenz M., Northrop J. P., Ringold G. M., Danielsen M. 1987; Lipofectin: a highly efficient, lipid-mediated DNA-transfection procedure. Proceedings of the National Academy of Sciences, U.S.A. 84:7413–7417
    [Google Scholar]
  21. Fenouillet E., Gluckman J. C., Bahraoui E. 1990; Role of N-linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1. Journal of Virology 64:2841–2848
    [Google Scholar]
  22. Folks T. M., Powell D., Lightfoote M., Koenig S., Fauci A. S., Benn S., Rabson A., Daugherty D., Gendelman H. E., Hoggan M. D., Venkatesan S., Martin M. A. 1986; Biological and biochemical characterization of a cloned Leu-3 cell surviving infection with the acquired immune deficiency syndrome retrovirus. Journal of Experimental Medicine 164:280–290
    [Google Scholar]
  23. Gartner S., Markovitz P., Markovitz D. M., Kaplan M. H., Gallo R. C., Popovic M. 1986; The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233:215–219
    [Google Scholar]
  24. Gilbert M., Kirihara J., Mills J. 1991; Enzyme-linked immunoassay for human immunodeficiency virus type 1 envelope glycoprotein 120. Journal of Clinical Microbiology 29:142–147
    [Google Scholar]
  25. Harouse J. M., Kunsch C., Hartle H. T., Laughlin M. A., Hoxie J. A., Wigdahl B., Gonzales-Scarano F. 1989; CD4-independent infection of human neural cells by human immunodeficiency virus type 1. Journal of Virology 63:2527–2533
    [Google Scholar]
  26. Ho D. D., Rota T. R., Hirsch M. S. 1986; Infection of monocyte/macrophages by human T lymphotropic virus type III. Journal of Clinical Investigation 77:1712–1715
    [Google Scholar]
  27. Hoekstra D., de Boer T., Klappe K., Wilschut J. 1984; Fluorescence method for measuring the kinetics of fusion between biological membranes. Biochemistry 23:5675–5681
    [Google Scholar]
  28. Hoffman A. D., Banapour B., Levy J. A. 1985; Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology 147:326–335
    [Google Scholar]
  29. Hope M. J., Bally M. B., Webb G., Cullis P. R. 1985; Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential. Biochimica et biophysica acta 812:55–65
    [Google Scholar]
  30. Ikeuchi K., Kim S., Byrn R. A., Goldring S. R., Groopman J. E. 1990; Infection of nonlymphoid cells by human immunodeficiency virus type 1 or type 2. Journal of Virology 64:4226–4231
    [Google Scholar]
  31. Innes C. L., Smith P. B., Langenbach R., Tindall K. R., Boone L. R. 1990; Cationic liposomes (lipofectin) mediate retroviral infection in the absence of specific receptors. Journal of Virology 64:957–961
    [Google Scholar]
  32. Kawasaki N., Kawasaki T., Yamashina I. 1985; Mannan-binding protein and conglutinin in bovine serum. Journal of Biochemistry 98:1309–1320
    [Google Scholar]
  33. Klatzmann D., Champagne E., Chamaret S., Gruest J., Guetard D., Hercend T., Gluckman J.-C., Montagnier L. 1984; T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature, London 312:767–768
    [Google Scholar]
  34. Konopka K., Davis B. R., Larsen C. E., Alford D. R., Debs R. J., Düzgüneș N. 1990; Liposomes modulate human immunodeficiency virus infectivity. Journal of General Virology 71:2899–2907
    [Google Scholar]
  35. Konopka K., Davis B. R., Düzgüneș N. 1991; HIV-1 infection of a non-CD4-expressing variant of HUT-78 cells: lack of inhibition by Leu3a antibodies and enhancement by cationic DOTMA liposomes. In Mechanisms and Specificity of HIV Entry into Host Cells Edited by Düzgüneș N. New York: Plenum Press; (in press)
    [Google Scholar]
  36. Kowalski M., Potz J., Basiripour L., Dorfman T., Goh W. C., Terwilliger E., Dayton A., Rosen C., Haseltine W., Sodroski J. 1987; Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 237:1351–1355
    [Google Scholar]
  37. Kowalski M., Bergeron L., Dorfman T., Haseltine W., Sodroski J. 1991; Attentuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein. Journal of Virology 65:281–291
    [Google Scholar]
  38. Larkin M., Childs R. A., Matthews T. J., Thiel S., Mizuochi T., Lawson A. M., Savill J. S., Haslett C., Diaz R., Feizi T. 1989; Oligosaccharide-mediated interactions of the envelope glycoprotein gp120 of HIV-1 that are independent of CD4 recognition. AIDS 3:793–798
    [Google Scholar]
  39. Larsen C. E., Alford D. R., Young L. J. T., McGraw T. P., Düzgüneș N. 1990; Fusion of simian immunodeficiency virus with liposomes and erythrocyte ghosts: effect of liposome composition, pH and calcium. Journal of General Virology 71:1947–1955
    [Google Scholar]
  40. Lasky L. A., Nakamura G., Smith D. H., Fennie C., Shimasaki C., Patzer E., Berman P., Gregory T., Capon D. J. 1987; Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 50:975–985
    [Google Scholar]
  41. Li X. L., Moudgil T., Vinters H. V., Ho D. D. 1990; CD4-independent productive infection of a neuronal cell line by human immunodeficiency virus type 1. Journal of Virology 64:1383–1387
    [Google Scholar]
  42. Lifson J. D. 1991; Fusion of HIV-infected cells with uninfected cells; CD4-dependent HIV-induced cell fusion. In Membrane Fusion Techniques, Method in Enzymology Edited by Düzgüneș N. New York: Academic Press; (in press)
    [Google Scholar]
  43. Lifson J. D., Feinberg M. B., Reyes G. R., Rabin L., Banapour B., Chakrabarti S., Moss B., Wong-Staal F., Steimer K. S., Engleman E. G. 1986a; Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature, London 323:725–728
    [Google Scholar]
  44. Lifson J., Coutre S., Huang E., Engleman E. 1986b; Role of envelope glycoprotein carbohydrate in human immunodeficiency virus (HIV) infectivity and virus-induced cell fusion. Journal of Experimental Medicine 64:2101–2120
    [Google Scholar]
  45. Longe P., Cabiaux V., Long L., Ruysschaert J. M. 1986; Fusion of Newcastle disease virus with liposomes: role of the lipid composition of liposomes. Biochimica et biophysica acta 858:312–316
    [Google Scholar]
  46. Loyter A., Citovsky V., Blumenthal R. 1988; The use of fluorescence dequenching measurements to follow viral membrane fusion events. Methods of Biochemical Analysis 33:129–164
    [Google Scholar]
  47. McDougal S. J., Nicholson J. K. A., Cross G. D., Cort S. P., Kennedy M. S., Mawle A. C. 1986; Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry. Journal of Immunology 137:2937–2944
    [Google Scholar]
  48. Maddon P. J., Dalgleish A. G., McDougal J. S., Clapham P. R., Weiss R. A., Axel R. 1986; The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333–348
    [Google Scholar]
  49. Malone R. W., Felgner P. L., Verma I. M. 1989; Cationic liposome-mediated RNA transfection. Proceedings of the National Academy of Sciences, U.S.A. 86:6077–6081
    [Google Scholar]
  50. Moore J. P., McKeating J. A., Weiss R. A., Sattentau Q. J. 1990; Dissociation of gpl20 from HIV-1 virions induced by soluble CD4. Science 250:1139–1142
    [Google Scholar]
  51. Nicholson J. K. A., Cross G. D., Callaway C. S., McDougal J. S. 1986; In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). Journal of Immunology 137:323–329
    [Google Scholar]
  52. Ou C. Y., Kwok S., Mitchell S. W., Mack D. H., Sninsky J. J., Krebs J. W., Feorino P., Warfield D., Schochetman G. 1988; DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science 239:295–297
    [Google Scholar]
  53. Patterson S., Knight S. 1987; Susceptibility of human peripheral blood dendritic cells to infection by human immunodeficiency virus. Journal of General Virology 68:1177–1181
    [Google Scholar]
  54. Pelchen-Matthews A., Armes J. E., Marsh M. 1989; Internalization and recycling of CD4 transfected into HeLa and NIH3T3 cells. EMBO Journal 8:3641–3649
    [Google Scholar]
  55. Pincus S. H., Wehrly K., Chesebro B. 1991; Use of a focal infectivity assay for testing susceptibility of HIV to antiviral agents. Bio/Techniques 10:336–342
    [Google Scholar]
  56. Robinson E. R. Jr, Montefiori D. C., Mitchell W. M. 1987; Evidence that mannosyl residues are involved in human immunodeficiency virus type (HIV-1) pathogenesis. AIDS Research and Human Retroviruses 3:265–281
    [Google Scholar]
  57. Sattentau Q., Dalgleish A. G., Weiss R. A., Beverly P. C. L. 1986; Epitopes of the CD4 antigen and HIV infection. Science 234:1120–1123
    [Google Scholar]
  58. Smith D. H., Byrn R. A., Marsters S. A., Gregory T., Groopman J. E., Capon D. J. 1987; Blocking of HIV-1 infectivity by a soluble secreted form of the CD4 antigen. Science 238:1704–1707
    [Google Scholar]
  59. Sodroski J., Goh W. C., Rosen C., Campbell K., Haseltine W. 1986; Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature, London 322:470–474
    [Google Scholar]
  60. Szoka F., Olson F., Heath T., Vail W., Mayhew E., Papahadjopoulos D. 1980; Preparation of unilamellar liposomes of intermediate size (0.1–0.2 µm) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes. Biochimica et biophysica acta 601:559–571
    [Google Scholar]
  61. Tateno M., Gonzales-Scarano F., Levy J. A. 1989; Human immunodeficiency virus can infect CD4-negative human fibroblastoid cells. Proceedings of the National Academy of Sciences, U.S.A. 86:4287–4290
    [Google Scholar]
  62. Toyoshima K., Vogt P. K. 1969; Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions. Virology 38:414–426
    [Google Scholar]
  63. Tschachler E., Groh V., Popovic M., Mann D. L., Konrad K., Safai B., Eron L., Veronese F. D., Wolff K., Stingl G. 1987; Epidermal Langerhans cells — a target for HTLV-III/LAV infection. Journal of Investigative Dermatology 88:233–237
    [Google Scholar]
  64. Weber J., Clapham P., McKeating J., Stratton M., Robey E., Weiss R. 1989; Infection of brain cells by diverse human immunodeficiency virus isolates: role of CD4 as receptor. Journal of General Virology 70:2653–2660
    [Google Scholar]
  65. Weiss R. A., Clapham P. R., McClure M., Marsh M. 1989; The CD4 receptor for the AIDS virus. Biochemical Society Transactions 17:644–647
    [Google Scholar]
  66. Zack J. A., Arrigo S. J., Weitsman S. R., Go A. S., Haislip A., Chen I. S. Y. 1990; HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213–222
    [Google Scholar]
  67. Zaia J. A., Rossi J. J., Murakawa G. J., Spallone P. A., Stephens D. A., Kaplan B. E., Eritja R., Wallace R. B., Cantin E. M. 1988; Inhibition of human immunodeficiency virus by using an oligonucleoside methylphosphonate targeted to the tat-3 gene. Journal of Virology 62:3914–3917
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-72-11-2685
Loading
/content/journal/jgv/10.1099/0022-1317-72-11-2685
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error